Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study

ConclusionsCrisaborole QD was effective and well tolerated for long-term maintenance treatment and flare reduction in adult and pediatric patients with mild-to-moderate AD.Trial RegistrationClinicalTrials.gov, NCT04040192, 31 July 2019.

http://link.springer.com/10.1007/s40257-023-00780-w

Source: American Journal of Clinical Dermatology - May 15, 2023 Category: Dermatology Source Type: research